In vitro elimination of anti-infective drugs by the Seraph® 100 Microbind® affinity blood filter
Open Access
- 21 May 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 13 (3) , 421-424
Abstract
In August 2019, the European Union licensed the first ever haemoperfusion device aimed to reduce pathogens in the blood. The core of the adsorber consists of ultra-high molecular weight polyethylene beads with endpoint-attached heparin. These beads utilize pathogen inherent adhesion mechanisms to reduce pathogen load. So far, it is unknown whether the device has an effect on anti-infective drug concentrations. The aim of this study was to investigate the in vitro adsorption of multiple anti-infective drugs from human plasma. In this in vitro study, 18 anti-infective drugs were administered to human donor plasma and pumped through the heparin-coated pathogen adsorber (Seraph® 100 Microbind®Affinity Blood Filter; ExThera Medical Corp., Martinez, CA, USA) at a plasma flow rate of 250 mL/min for 60 min. Pre- and post-adsorber plasma samples were quantified after 5, 15, 30 and 60 min. We found a reduction ratio (RR) in anti-infective plasma levels between −1% and 62%. This decrease occurred mainly in the first 5 min of the experiment (RR0–5 −4 to 62%). Mean plasma clearance rates ranged between –11.93 mL/min (fluconazole) and 4.86 mL/min (clindamycin). The highest RRs were measured for aminoglycosides (tobramycin 62% and gentamycin 59%). The elimination of anti-infective drugs by the Seraph is neglectable in all but 2 of 18 of the investigated substances. Aminoglycosides may be adsorbed by the device during their first pass.Keywords
Funding Information
- ExThera Medical Corp
- InfectoPharm Arzneimittel & Consilium GmbH
This publication has 12 references indexed in Scilit:
- Single- and multiple-dose pharmacokinetics and total removal of colistin in critically ill patients with acute kidney injury undergoing prolonged intermittent renal replacement therapyJournal of Antimicrobial Chemotherapy, 2019
- SaO040TREATMENT OF BACTEREMIA DURING DIALYSIS USING A BIOMIMETIC SORBENT HEMOPERFUSION DEVICE - RESULTS OF AN ONGOING FIRST-IN-HUMAN STUDYNephrology Dialysis Transplantation, 2018
- Bacterial capture efficiency in fluid bloodstream improved by bendable nanowiresNature Communications, 2018
- Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from Blood by Heparin-Functional Hemoperfusion MediaPLOS ONE, 2014
- Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort studyCritical Care, 2014
- A new strategy to fight antimicrobial resistance: the revival of old antibioticsFrontiers in Microbiology, 2014
- Highly Efficient Enzyme-Functionalized Porous Zirconia Microtubes for Bacteria FiltrationEnvironmental Science & Technology, 2012
- Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2011
- Effect of Preexposure to Aminoglycosides onIn VitroAdsorption of Amikacin by Polyacrylonitrile HemofiltersAntimicrobial Agents and Chemotherapy, 2011
- The Hek Outer Membrane Protein of Escherichia coli Strain RS218 Binds to Proteoglycan and Utilizes a Single Extracellular Loop for Adherence, Invasion, and AutoaggregationInfection and Immunity, 2008